In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM

Open source

DOI
10.1084/jem.20120950
Published
2013 May 6
Container
The Journal of experimental medicine
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1084/jem.20120950,
  title = {In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.},
  author = {Pichiorri F and Palmieri D and De Luca L and Consiglio J and You J and Rocci A and Talabere T and Piovan C and Lagana A and Cascione L and Guan J and Gasparini P and Balatti V and Nuovo G and Coppola V and Hofmeister CC and Marcucci G and Byrd JC and Volinia S and Shapiro CL and Freitas MA and Croce CM},
  year = {2013},
  journal = {The Journal of experimental medicine},
  doi = {10.1084/jem.20120950},
  url = {https://doi.org/10.1084/jem.20120950}
}

RIS

TY  - JOUR
TI  - In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
AU  - Pichiorri F
AU  - Palmieri D
AU  - De Luca L
AU  - Consiglio J
AU  - You J
AU  - Rocci A
AU  - Talabere T
AU  - Piovan C
AU  - Lagana A
AU  - Cascione L
AU  - Guan J
AU  - Gasparini P
AU  - Balatti V
AU  - Nuovo G
AU  - Coppola V
AU  - Hofmeister CC
AU  - Marcucci G
AU  - Byrd JC
AU  - Volinia S
AU  - Shapiro CL
AU  - Freitas MA
AU  - Croce CM
PY  - 2013
JO  - The Journal of experimental medicine
DO  - 10.1084/jem.20120950
UR  - https://doi.org/10.1084/jem.20120950
ER  - 

APA

F, P., D, P., L, D. L., J, C., J, Y., A, R., T, T., C, P., A, L., L, C., J, G., P, G., V, B., G, N., V, C., CC, H., G, M., JC, B., S, V., CL, S., MA, F., & CM, C. (2013). In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.. The Journal of experimental medicine. https://doi.org/10.1084/jem.20120950

Source records